The missing mass of morality: A new fitpack design for hepatitis C prevention in sexual partnerships

QR Code

The missing mass of morality: A new fitpack design for hepatitis C prevention in sexual partnerships

In the West, most hepatitis C transmission occurs through the sharing of equipment used for injecting drugs, and most sharing occurs between sexual partners. Despite this, little is known about how injecting practice, including equipment use, is managed in these partnerships. This article draws on s...

Full description

Bibliographic Details
Main Author:	Fraser, Suzanne
Format:	Journal Article
Published:	Elsevier BV 2013
Subjects:	Bruno Latour Injecting equipment design Sexual partnerships Injecting drug use Hepatitis C Individual responsibility
Online Access:	http://hdl.handle.net/20.500.11937/45153

Similar Items

Minor grip: on the constitution of morality, agency and affectivity with technology
by: Bakhtiar, Siavash
Published: (2018)

Comorbities and medications of patients with chronic hepatitis C under specialist care in the UK
by: Hudson, Benjamin, et al.
Published: (2017)

Concordance between self-reported and actual hepatitis C virus infection status in a cohort of people who inject drugs
by: O’Keefe, D., et al.
Published: (2013)

The ins and outs of injection in Western Australia
by: Carruthers, Susan
Published: (2003)

"Petunias too, please": further thoughts on achieving control of hepatitis C in Australia
by: Loxley, Wendy
Published: (1997)

Does informing people who inject drugs of their hepatitis C status influence their injecting behavior? Analysis of the Networks II study
by: Aspinall, E., et al.
Published: (2014)

The Australian Study of HIV and Injecting Drug Use. Part I: Prevalence for HIV, hepatitis B and hepatitis C among injecting drug users in four Australian cities
by: Loxley, Wendy, et al.
Published: (1997)

Governing through problems: The formulation of policy on amphetamine-type stimulants (ATS) in Australia
by: Fraser, Susan, et al.
Published: (2011)

The Australian Study of HIV and Injecting Drug Use. Part 11: Predicting exposure to hepatitis C and hepatitis B
by: Carruthers, Susan, et al.
Published: (1997)

Effectiveness of an education intervention on Hepatitis C treatment adherence among Libyan patients in a medical center in Tripoli
by: Adam, Samia Ibrahim Mohamed
Published: (2018)

Harm reduction and hepatitis C: On the ethics and politics of prevention and treatment
by: Fraser, S., et al.
Published: (2011)

Risk factors for hepatitis c virus infection among adult patients at a public hospital in Kedah, Malaysia
by: Mohd Suan, Mohd Azri
Published: (2019)

Molecular epidemiology and antiviral resistance characterization of Hepatitis C virus circulating in Africa and Brazil
by: Adeboyejo, Kazeem Adeyinka
Published: (2020)

Authenticity and Diversity: Enhancing Australian Hepatitis C Prevention Messages
by: Winter, R., et al.
Published: (2013)

Research note: Laboratory study of the influence of changing the injection rate on the geometry of the fluid front and on P-wave ultrasonic velocities in sandstone
by: Lopes, Sofia, et al.
Published: (2012)

A Statistical Experimental Study on Shrinkage of Injection-Molded Part
by: Rajalingam, Sokkalingam, et al.
Published: (2012)

Hepatitis C treatment - better outcomes through partner support
by: Chapman, Fleur, et al.
Published: (2012)

Perceptions of risk and safety within injection settings: Injection drug users' reasons for attending a supervised injecting facility in Vancouver, Canada
by: Small, W., et al.
Published: (2012)

Preventing hepatitis C virus transmission among young people in the justice system
by: Lenton, E., et al.
Published: (2013)

HIV risk behaviour among injecting drug users in Perth: the Australian National AIDS and Injecting Drug Use Study
by: Loxley, Wendy, et al.
Published: (1992)

Doing the possible: harm reduction, injecting drug use and blood borne viral infections in Australia
by: Loxley, Wendy
Published: (2000)

Translational considerations in injectable cell-based therapeutics for neurological applications: concepts, progress and challenges
by: Amer, Mahetab H., et al.
Published: (2017)

Design, Analysis and Fabrication of Plastic Injection Mould for Tensile Test Specimen
by: Mohd Ariffin, Mohd Khairol Anuar
Published: (2001)

Citizens who inject drugs: the 'Fitpack' study
by: Lenton, Simon, et al.
Published: (2000)

Hepatic elastin content is predictive of adverse outcome in advanced fibrotic liver disease
by: Kendall, Timothy, et al.
Published: (2018)

High resolution sequencing of hepatitis C virus reveals limited intra-hepatic compartmentalization in end-stage liver disease
by: Hedegaard, Ditte L., et al.
Published: (2017)

An investigation into the thermal management and control of ceramic injection moulding die-tools
by: Bianchi, Maria Floriana
Published: (2020)

MBOAT7 rs641738 increases risk of liver inflammation and transition to fibrosis in chronic hepatitis C
by: Thabet, Khaled, et al.
Published: (2016)

Development of an in vitro model to screen the foreign body response towards hydrogel depot injections
by: Stewart, Chloe L
Published: (2023)

Duration of subcutaneous heparin injections : effect on bruising and pain.
by: Chan, Harriet S. C.
Published: (2000)

Rates of injection in prison in a sample of Australian injecting drug users
by: Fetherston, James, et al.
Published: (2013)

An interchangeable turning sprue bushing (ITSB) system in a family mould / Saiful Bahri Mohd Yasin
by: Mohd Yasin, Saiful Bahri
Published: (2014)

Changes in drug use and HIV/AIDS risk-taking 1989-90
by: Marsh, Alison, et al.
Published: (1995)

AIDS and injecting drug use: very risky behaviour in a Perth sample of injecting drug users
by: Loxley, Wendy, et al.
Published: (1994)

Co-infections of hepatitis B patients with other hepatitis viruses and their serological, biological and prognostic markers
by: Hudu Abdullahi, Shuaibu
Published: (2017)

Trace analysis of environmental matrices by large-volume injection and liquid chromatography-mass spectrometry
by: Busetti, Francesco, et al.
Published: (2011)

Maintaining core business and key drivers in mining-Indigenous partnerships: releasing value through recognising difference.
by: Morgan, H., et al.
Published: (2014)

A Preliminary Study on Optimizing Injection Moulding Process by Using Response Surface Method
by: Sokkalingam, Rajalingam
Published: (2009)

Recombinant human L-ficolin directly neutralizes hepatitis C virus entry
by: Hamed, Mohamed R., et al.
Published: (2014)

The cost of treatment failure: resource use and costs incurred by hepatitis C virus genotype 1-infected patients who do or do not achieve sustained virological response to therapy
by: Backx, M., et al.
Published: (2014)